Medify Solutions Ltd.

EMIS Prepares for MedifyRemote Roll Out

    Toronto, Canada, November 2 (ots/PRNewswire) - EMIS, the UK's leading provider of IT systems to the primary care market is preparing to make the MedifyRemote product available across its UK customer base.

    Approximately 55% of all doctors in the UK currently use EMIS software each day.

    EMIS has been instrumental, through the NHS pilots, making sure the product not only meets customers needs but also the pre-requisite national standards of security required for a national solution. MedifyRemote, delivered as part of the EMIS Partner Programme, will lead the way in real time mobile secure access for fully functional remote patient record access.

    EMIS is a keen supporter of leading edge technologies that can improve the provision of healthcare, benefiting clinicians and patients alike.

    MedifyRemote delivers the highest approved level of security for remote access to patient notes anywhere anytime and due to the functionality of MedifyRemote, Doctors can access and view patient notes and historical information, to ensure continuity of care and clinical accuracy. In a single secure transaction, the patient visit and any actions are recorded directly through the MedifyRemote product and updated real-time into the patient's medical record held at the doctor's surgery.

    MedifyRemote will be available through Medify's approved, secure mobile connection to the NHS National Spine (N3) for viewing and updating patient records.

    The MedifyRemote product will be available on a Microsoft platform and Blackberry devices alike.

    Darryl Cox, EMIS Project director, said: "Working on this project in partnership with Medify has been exciting and rewarding, delivering a project that creates a leading edge solution". GPs are increasingly mobile and it's vital that they have secure, safe and easy access to their patients' medical records on the go.

    Ian O 'Reilly, CEO Medify Solutions, commented: "We all believed in the product and the project, to be in a position with EMIS to have reached this point is real justification. Working closely with EMIS to not only take to market a product which we believe gives customer satisfaction, but through the recent EMIS National User Group conference feedback, we now know the product is in demand by Healthcare purchasers. To ensure the MedifyRemote proposition is made commercially available through EMIS's leading UK position, is the commercial realisation of the Medify business plan.

    Medify Solutions Ltd - Pink Sheets MDFY

    www.medifysolutions.com

    This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch

Contact:
For further information: Chris Hill - enquiries@medifysolutions.com



Weitere Meldungen: Medify Solutions Ltd.

Das könnte Sie auch interessieren: